New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
06:38 EDTSVASinovac Biotech enters technology transfer agreement with Intravacc
Sinovac Biotech announced that it has entered into a license agreement with the Institute for Translational Vaccinology, or Intravacc, from The Netherlands to develop and commercialize the Sabin Inactivated Polio Vaccine, or sIPV, for distribution to China and other countries. According to the agreement, Sinovac has committed to commercializing the vaccine in China, inclusive of conducting clinical trials, obtaining regulatory approval, and launching the sIPV vaccine. In addition, Sinovac has committed to having the capacity to supply, or making arrangements for the supply of, sIPV to the public sector of other countries in sufficient quantities to make a meaningful contribution to meeting global demand.
News For SVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2016
06:15 EDTSVASinovac announces receipt of competing non-binding 'going private' proposal
Subscribe for More Information
February 1, 2016
06:16 EDTSVASinovac Biotech receives preliminary non-binding acquisition proposal
Subscribe for More Information
January 28, 2016
06:15 EDTSVASinovac Biotech announces issuance of GMP certificate for EV71 vaccine
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use